Genetic profile and determinants of homocysteine levels in Kazakhstan patients with breast cancer

Ainur Akilzhanova, Zhannur Nurkina, Kuvat Momynaliev, Erlan Ramanculov, Zhaxybai Zhumadilov, Tolebay Rakhypbekov, Naomi Hayashida, Masahiro Nakashima, Noboru Takamura

Research output: Contribution to journalArticlepeer-review

25 Citations (Scopus)


Aim: To analyze associations between homocysteine level, MTHFR and FTO rs1477196 polymorphisms and folate status in patients with breast cancer (BC) in order to clarify determinants of hyperhomocysteinemia. Patients and Methods: The study included 315 BC cases and 604 controls. Results: The MTHFRC677T genotype was associated with an increased incidence of BC [Odds ratio (OR)=1.71; 95% Confidential interval (CI)=1.21-2.43]. The MTHFR A1298C genotype was associated with a decreased risk of BC [OR=0.68; 95% CI: 0.49-0.95]. The homocysteine level was not associated with either MTHFR C677T or A1298C, nor with FTO rs1477196, but was inversely correlated with folate status in cancer cases (p<0.0001) and tended to be higher in patients with the MTHFR 677TT genotype. The folate level (p<0.0005) was an independent predictor of hyper-homocysteinemia in patients with BC. Conclusion: These results suggest an important role of homocysteine in breast tumorigenesis. Further studies are warranted to investigate how combined MTHFR genotypes exert their effects on cancer susceptibility.

Original languageEnglish
Pages (from-to)4049-4060
Number of pages12
JournalAnticancer Research
Issue number9
Publication statusPublished - Sep 1 2013


  • Breast cancer
  • FTO
  • Folate
  • Homocysteine
  • Kazakhstan
  • Polymorphism

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Genetic profile and determinants of homocysteine levels in Kazakhstan patients with breast cancer'. Together they form a unique fingerprint.

Cite this